{
  "report_rows": [
    {
      "kpi": "Total Revenue Q2 2026",
      "prediction": "BEAT",
      "answer": "pred ~$2,200M vs. cons $2,155M",
      "confidence": "HIGH"
    },
    {
      "kpi": "Operating EPS Q2 2026",
      "prediction": "BEAT",
      "answer": "pred ~$1.97 vs. cons $1.905",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic Growth Q2 2026",
      "prediction": "BEAT",
      "answer": "pred ~7.5-8.0% vs. cons 7.01%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Operating EPS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$6.60-$6.75 vs. cons $6.547",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Organic Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~3%-4% vs. cons 2.76%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Operating Margin (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 21%-21.5% maintained vs. cons UNVERIFIED",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 Organic Growth (2026Q3)",
      "prediction": "LOWER",
      "answer": "guide ~0%-2% vs. FY run-rate (known ERP reversal)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 0.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 Q3 reversal mechanics drive near-term estimate cuts even as FY is raised; stock has already discounted much of the beat in the +13.7% idio pre-print run",
  "day5_confidence": "MEDIUM"
}